Britannia Life Sciences Inc (L020) Financial Statements
Britannia Life Sciences Inc Financial Overview
Britannia Life Sciences Inc's market cap is currently $7.28M. The company's EPS TTM is $0.09; its P/E ratio is 0.76; Britannia Life Sciences Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 25 | Mar 25 | Jun 23 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 474.83K | $ 369.28K | $ 7.57M | $ 6.40M | $ 7.30M |
| Gross Profit | $ 38.86K | $ 27.33K | $ 4.85M | $ 4.64M | $ 5.26M |
| Operating Income | $ -1.46M | $ -2.25M | $ 173.00K | $ 177.74K | $ 379.57K |
| EBITDA | $ -1.39M | $ -4.39M | $ -1.90M | $ 6.95M | $ -10.77M |
| Net Income | $ 13.07M | $ 7.39M | $ -4.77M | $ 5.08M | $ -15.46M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 17.14M | $ 7.85M | $ 1.32M | $ 2.60M | $ 1.63M |
| Total Assets | $ 23.87M | $ 11.61M | $ 22.26M | $ 23.55M | $ 21.09M |
| Total Debt | $ 229.14K | $ 1.86M | $ 7.29M | $ 8.41M | $ 5.19M |
| Net Debt | $ -1.10M | $ -5.99M | $ 5.96M | $ 5.81M | $ 3.56M |
| Total Liabilities | $ 3.12M | $ 5.31M | $ 15.59M | $ 12.49M | $ 15.61M |
| Stockholders' Equity | $ 20.75M | $ 6.30M | $ 2.44M | $ 7.02M | $ 1.35M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.16M | $ -2.62M | $ 1.75M | $ 874.41K | $ 2.71M |
| Operating Cash Flow | $ -1.16M | $ -2.62M | $ 2.09M | $ 1.22M | $ 2.80M |
| Investing Cash Flow | $ -5.25M | $ 11.27M | $ -1.44M | $ -3.32M | $ 653.95K |
| Financing Cash Flow | $ -110.77K | $ -2.17M | $ -1.97M | $ 2.95M | $ -2.58M |
Currency in CAD
